4.5 Review

Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation

Journal

VASCULAR PHARMACOLOGY
Volume 82, Issue -, Pages 1-10

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2015.10.009

Keywords

Atherothrombosis; Lipoproteins; Endothelial function; Platelets; Coagulation

Funding

  1. VICI grant from The Netherlands Organization for Scientific Research [91813603]
  2. Dutch Heart Foundation [2007T056]

Ask authors/readers for more resources

Atherothrombosis is a complication of atherosclerosis that causes acute cardiovascular events such as myocardial infarction and stroke. Circulating lipid levels are highly correlated with atherosclerotic plaque development. In addition, experimental evidence suggests that lipids also directly influence thrombosis and influence the risk and the outcome of acute cardiovascular events. Plasma lipoproteins influence three aspects important to atherothrombosis: endothelial function, platelet aggregation (primary coagulation) and secondary coagulation. Overall, VLDL, LDL and oxLDL promote thrombus formation, whereas HDL shows antithrombotic actions. In this review we will address the current knowledge about modulation of atherothrombosis by lipoproteins, summarizing findings from in vitro and in vivo animal studies, as well as from observational and interventional studies in humans. We will conclude with future perspectives for lipid modulation in the prevention of atherothrombosis. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available